Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04004143
Other study ID # QLS2014
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2013
Est. completion date December 31, 2014

Study information

Verified date June 2019
Source Shenzhen Center for Chronic Disease Control
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Adult subjects were recruited from a health examination center. Their fasting blood samples were collected for laboratory analyses of multiple measures including mineral, glucose, lipids, etc.


Recruitment information / eligibility

Status Completed
Enrollment 1520
Est. completion date December 31, 2014
Est. primary completion date November 30, 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 85 Years
Eligibility Inclusion Criteria:

- adult volunteer

- Han population

- living in Shenzhen City for > 2 y

Exclusion Criteria:

- caught by organic diseases

- in pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Shenzhen Center for Chronic Disease Control Shenzhen Qilinshan Sanatorium, Sun Yat-sen University

Outcome

Type Measure Description Time frame Safety issue
Primary circulation concentration of glucose Glucose (mmol/L) was measured in less than 4 hours after sample collection less than 4 hours
Primary circulation concentrations of 4 types of lipids TG, TC, LDLC, and HDLC (mmol/L) were measured in less than 4 hours after sample collection less than 4 hours
Primary circulation concentrations of 5 minerals all samples were stored at minus 75 degrees Celsius until ready for analysis collectively on a ICP-MS machine for calcium, cobalt, iron, selenium, and zinc (ng/ml) less than 3 years
Secondary body mass index body weight (kg) and hight (m) were measured when the volunteers were visiting the health examination center, and the body mass index was calculated later by the formula of body weight/ hight/ hight (kg/m^2). less than 1 month
Secondary circulation concentration of 25OHD all samples were stored at minus 75 degrees Celsius until ready for analysis collectively with ELISA kits (nmol/L) less than 3 years
See also
  Status Clinical Trial Phase
Completed NCT00001154 - Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Recruiting NCT02837367 - Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People N/A
Active, not recruiting NCT02223793 - Vascular Lifestyle-Intervention and Screening in Pharmacy N/A
Active, not recruiting NCT02600338 - Meta-analyses of the Effect of Legumes on Blood Pressure N/A
Completed NCT02163044 - The Hellenic Postprandial Lipemia Study (HPLS)
Recruiting NCT01972113 - Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study) N/A
Recruiting NCT01705873 - Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen N/A
Completed NCT01764295 - Clinical Study for Patients With Hypertension Associated With Dyslipidemia Phase 3
Completed NCT01531062 - Effect of Nigella Sativa on Lipid Profiles in Elderly Phase 2
Completed NCT01990391 - Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities N/A
Terminated NCT01414166 - Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108) Phase 3
Recruiting NCT01670968 - HIV Reverse Cholesterol Transport Study
Completed NCT00977288 - A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029) Phase 2
Completed NCT01285544 - The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia Phase 4
Withdrawn NCT00664287 - Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082) Phase 3
Completed NCT00768274 - Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol Phase 1/Phase 2
Completed NCT01483235 - Reduced Cardiac Rehabilitation Program N/A
Completed NCT00300430 - Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. Phase 3
Completed NCT00312923 - Preliminary Study of Safety and Efficacy of Policosanol Phase 2